SINO-AMERICAN BIOTECHNOLOGY AND PHARMACEUTICAL PROFESSIONAL ASSOCIATION

EIN: 731627787 501(c)(3) Science & Technology

SAN DIEGO, CA

Total Revenue
$207,805
Total Expenses
$213,499
Total Assets
$320,294
Net Assets
$320,294
🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Sign In — Free (10 views/day)

Financial Trends

Organization Details

Formation Year
2002
Legal Domicile
CA
Principal Officer
PETER Q HUANG
Phone
7733084289
Tax Period
2018-01-01 to 2018-12-31

SINO-AMERICAN BIOTECHNOLOGY AND PHARMACEUTICAL PROFESSIONAL ASSOCIATION, founded in 2002, is a small nonprofit in the Science & Technology sector that reported $208K in total revenue in fiscal year 2018. Revenue fell 29% from the prior year — a significant decline worth monitoring.

Mission

SABPA'S PRIMARY MISSION AND MOST SIGNIFICANT ACTIVITIES ARE TO PROMOTE SCIENCE AND INNOVATION. (1). TO PROVIDE FORUMS FOR FACILITATING INTERACTION AND COMMUNCATIONS AMONG BIOTECHINAL PROESSIONALSIONALS IN GLBOAL SCIENCE AND TECHNOLOGY ARENA;(2). TO PROMOTE INTERACTION AND COLLABORATION IN SCIENCE AND TECHNOLOGY ACROSS THE PACIFIC REGIONS; AND(3). TO STIMULATE AND NURTURE THE INNOVATIVE IDEAS, CUTTING-EDGE TECHNOLOGIES, ENTREPRENEURSHIP AND BRINGING PUBLIC AWARENESS OF THE BENEFITS OF BIOMEDICAL RESEARCH.

Program Service Accomplishments

Program 1
Expenses: $45,984 Revenue: $34,247

The 17th San Diego BioPharma & 6th Pacific Bio-Partnering Conference:San Diego BioPharma Conference, the flagship event of SABPA, has been featuring some of the most respectful figures in the fields...

Read more

The 17th San Diego BioPharma & 6th Pacific Bio-Partnering Conference:San Diego BioPharma Conference, the flagship event of SABPA, has been featuring some of the most respectful figures in the fields, from potential Nobel laureates and breakthrough innovators to multi-billion-dollar dealmakers. Many exciting stories from San Diego biopharma industry in the past year hit the global headlines and have ignited the passion that further fuels innovations. This year's topics included the pioneering exploration of gene therapies and proteome wide drug discovery, transformative academia research and its translation into life-saving therapeutics, the making of a multi-billion dollar deal, the challenges of navigating the drug R&D paths to ultimate success, and strategies to succeed in the ever-changing global market. SABPA Bio-Partnering is a great platform to explore opportunities in licensing, investment, fund raising, procurement and other collaboration deals. It is designed for people to pre-arrange 1-on-1 face-to-face meetings with potential partners/investors by using the online tool Partnering360*. Participants can upload their profiles to the platform and send invitations to other participants. Once the invitations are accepted, 30-minute private meetings will be arranged automatically. Participants have access to pre-scheduled 1-on-1 meetings in designated meeting areas during the conference, as well as access to Partnering360 database all year round. Bio-Partnering was hosted at the same time and same venue as San Diego Bio-Pharma Conference on June 9, 2018. Program Highlights:a. Ignyta's unlikely journey in precision medicine: From Dx start-up to global personalized healthcare companyb. A 2018 Breakthrough Prize Winner's insights on gene silencing therapyc. An industry veteran's insights on the trends, gaps and opportunities for delivering innovation to therapeutic applicationd. Neurocrine's extraordinary story of growth, failure, reinvention and ultimate successe. J&J's stories on unlocking the biological mysteries of many diseases of the brainf. Fresh update on the new initiatives of Chinese FDA and its future outlooks

Program 2
Expenses: $66,847 Revenue: $59,572

The 14th Annual Pacific Forum & 7th SABPA Bio-Partnering:As one of the flagship annual conferences organized by SABPA, Pacific Forum (PF) draws over 500 life sciences professionals from across the...

Read more

The 14th Annual Pacific Forum & 7th SABPA Bio-Partnering:As one of the flagship annual conferences organized by SABPA, Pacific Forum (PF) draws over 500 life sciences professionals from across the Pacific every year. This year's Pacific Forum packed with many top-notch speakers to discuss recent industry success stories and new models of collaborations from leaders of biomedical and pharmaceutical industry across the Pacific Rim.

Program 3
Expenses: $44,728 Revenue: $109,098

Numerous other events held by SABPA to address various issues of importance to the biotechnology and pharmaceutical industries:(a). The 2nd SABPA Frontier in Therapeutics and Diagnostics (FTD)...

Read more

Numerous other events held by SABPA to address various issues of importance to the biotechnology and pharmaceutical industries:(a). The 2nd SABPA Frontier in Therapeutics and Diagnostics (FTD) forumThis forum covered three hot topics, including liquid biopsy, gene editing and artificial intelligence. SABPA invited high-caliber speakers to share with audience the latest breakthroughs and their visions in these fields. There were two panel discussions focusing respectively on liquid biopsy and gene editing. Audience had the great opportunities to ask questions, share ideas, learn from the experts, as well as to network with their peers.Program Highlights* Game-changing liquid biopsy assays for early cancer diagnostics* Applications of gene editing in target identification and drug screening* Development of cutting-edge gene therapies using CRISPR technology* Liquid biopsy in drug development and patient care* Showcase of success stories of artificial intelligence in disease diagnostics* Applications of artificial intelligence in addressing unmet medical needs(b) The 21st SABPA Entrepreneur Symposium - Licensing of IP & Tech Transfer in Biotech ArenaThe mission of this symposium is to bring together ambitious members to create a free-thinking and stimulating environment. The committee welcomes experienced entrepreneurs, company executives, venture capitalists to present their real stories, experiences and perspectives.The committee aims to * To provide SABPA members knowledge about entrepreneurship and help those members who wish to pursue their own business interests.* To explore mechanisms that will help stimulate the creation of small and medium businesses to explore innovative methods to create a business enabling environment and strategies that can guide small business to grow and remain competitiveTo foster information exchange, cooperation and interaction among entrepreneurs, investors, established companies, government agencies, non-governmental organizations, and academia in San Diego and southern California.In 2018, SABPA held three Entrepreneur Symposium and covered the following three topics. * Licensing of IP & Tech Transfer in Biotech Arena* An Edge to Monetize Intellectual Property in the Greater China Region* Licensing Fundamentals for Business Executives and Startups(c). The 4th Annual SABPA-UCSD Career Development Forum:The goal of this forum is to foster professional growth, career improvement and personal development of young scientists. In the 4th Annual Joint Career Development Forum, co-organized by SABPA and UCSD Postdoc Association, we invited scientists and senior managers from a variety of local industries including life sciences, data science, and engineering to have a panel discussion. The Panelists shared with the audience their perspective of the industry hiring process and the qualifications, experience and many other attributes of successful candidates. d). The 13th Annual Biomedical ForumThe mission of this forum is to provide an attractive platform for entrepreneurs, scientists, investors, executives, and students to promote life sciences, biotechnology, and alliances across the biomedical industry in Southern California and Pacific Asia. The annual biomedical forum is one of the flagship events organized by SABPA OC/LA, which gathered elite speakers and attracted more than 100 attendees to discuss the development in the field of therapeutics and diagnostics.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Sign In — Free (10 views/day)

Financial Overview (2018)

Revenue Breakdown

Contributions & Grants $4,850
Program Service Revenue $202,917
Investment Income $38
Other Revenue $0
TOTAL REVENUE $207,805

Expense Breakdown

Grants Paid $0
Salaries & Benefits $0
Fundraising Expenses $0
Program Expenses $157,559
Other Expenses $213,499
TOTAL EXPENSES $213,499

Year-over-Year Comparison

2018 2017 Change
Revenue $207,805 $294,554 -0.3%
Expenses $213,499 $274,981 -0.2%
Net Income $-5,694 $19,573 -1.3%
Key Indicators
Grants to Organizations Grants to Individuals Lobbying Political Activity Foreign Activities Donor Advised Fund Schedule B Required
🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Sign In

Governance

Voting Members
21
Independent Members
21
Employees
N/A
Volunteers
N/A

Governance Policies

Conflict of Interest Policy
Whistleblower Policy
Document Retention Policy

Special Practices & Reported Activities

Operated a School
Operated a Hospital
Provided First Class Travel
Reported Conflict of Interest
Reported Asset Diversion
Excess Benefit Transaction
Made Political Expenditures
Engaged in Lobbying
Operated Donor Advised Fund
Maintained Art Collections
Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers
9
$0
Total Directors
21
$0
Key Employees
0
$0
Highest Compensated
0
reported
Name Title Hours/Week Role Reportable Comp Other Comp Total
YAHU LIU BOARD VICE CHAIRMAN 5.00
Officer Director
$0 $0 $0
PETER Q HUANG BOARD MEMBER & CFO 5.00
Officer Director
$0 $0 $0
STEPHANIE SHI PRESIDENT, SAN DIEGO CHAPT 5.00
Officer Director
$0 $0 $0
HUAINA LI PRESIDENT, OC/LA CHAPTER 5.00
Officer Director
$0 $0 $0
YINGHONG GAO BOARD SECRETARY 5.00
Officer Director
$0 $0 $0
MINGZHU ZHANG BOARD CHAIR 5.00
Officer Director
$0 $0 $0
YANBO YANG BOARD MEMBER 3.00
Director
$0 $0 $0
GUANG CHEN BOARD MEMBER 3.00
Director
$0 $0 $0
WEIJUN SHEN BOARD MEMBER 3.00
Director
$0 $0 $0
JC XU BOARD MEMBER 3.00
Director
$0 $0 $0
HUA GONG BOARD MEMBER 3.00
Director
$0 $0 $0
HUI LI BOARD MEMBER 3.00
Director
$0 $0 $0
YANG LIU BOARD MEMBER 3.00
Director
$0 $0 $0
YI LIU BOARD MEMBER 3.00
Director
$0 $0 $0
FRED OUYANG BOARD MEMBER 3.00
Director
$0 $0 $0
TAO WU BOARD MEMBER 3.00
Director
$0 $0 $0
XUEFENG ZHU BOARD MEMBER 3.00
Director
$0 $0 $0
KEVIN SHAO BOARD VICE CHAIRMAN & EVP, OC/LA CHAPTER 5.00
Officer Director
$0 $0 $0
MING GUO BOARD MEMBER 3.00
Director
$0 $0 $0
DOUBLE LI BOARD MEMBER 3.00
Director
$0 $0 $0
PETER ZHU BOARD MEMBER 3.00
Director
$0 $0 $0
JIANG PING TREASURE CHAIR, SD CHAPTER 5.00
Officer
$0 $0 $0
VIVIAN CHANG TREASURE CHAIR, OC/LA CHAP 5.00
Officer
$0 $0 $0
Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year Revenue Expenses Assets Net Income
2024 No data No data No data No data
2018 $207,805 $213,499 $320,294 $-5,694
Explore More Nonprofits
Top 100 Nonprofits in California Largest U.S. Nonprofits Best Rated Nonprofits Most Efficient Nonprofits

Compare SINO-AMERICAN BIOTECHNOLOGY AND PHARMACEUTICAL PROFESSIONAL ASSOCIATION with other nonprofits in California and across the country.